Cystoscopy Should Be Performed Next
This 69-year-old woman requires white light cystoscopy to complete her hematuria evaluation, as she is classified as high-risk based on age alone and has already completed upper tract imaging. 1
Risk Stratification
According to the 2020 AUA/SUFU guidelines, this patient falls into the high-risk category based on:
- Age ≥60 years (she is 69)
- 7 RBCs/HPF falls within the 3-10 range (low degree of hematuria, but age supersedes this)
The AUA risk stratification system clearly states that women or men age ≥60 years automatically qualify as high-risk, regardless of other factors 1.
Completed Workup Elements
She has already undergone:
- Negative CT urography (CTU) - appropriate upper tract imaging
- Negative urine cytology
- Negative FISH test
Missing Critical Component: Cystoscopy
White light cystoscopy is mandatory for bladder evaluation in all patients undergoing microscopic hematuria workup 1. The guideline provides a moderate recommendation (Evidence Level Grade C) that clinicians should perform white light cystoscopy in patients undergoing evaluation of the bladder for microhematuria.
Why Cystoscopy Cannot Be Skipped
- Bladder cancer is the most common malignancy detected in hematuria evaluations 2
- Upper tract imaging (CTU) does not adequately visualize the bladder mucosa, urethra, or ureteral orifices 3
- Even with negative cytology, cystoscopy remains essential as cytology has poor sensitivity for low-grade tumors 3
- This is a single episode of hematuria, but in a high-risk patient (age 69), evaluation is still warranted
Post-Cystoscopy Management
If Cystoscopy is Negative:
Given this is a single episode of microscopic hematuria with completely negative workup:
Surveillance approach 1:
- Repeat urinalysis at 12 months
- If repeat UA shows persistent or recurrent microhematuria: engage in shared decision-making regarding additional evaluation
- If repeat UA is negative: patient can be discharged from further hematuria-specific monitoring
Triggers for immediate re-evaluation 1:
- Gross hematuria develops
- Abnormal urinary cytology on follow-up
- Irritative voiding symptoms without infection
- Significant increase in degree of microhematuria
If Cystoscopy is Positive:
- Refer to urology for definitive management based on findings
Common Pitfall to Avoid
Do not assume the workup is complete without cystoscopy simply because imaging and cytology are negative. The 2020 AUA guidelines emphasize that cystoscopy and upper tract imaging are complementary, not interchangeable 1. Bladder lesions, particularly flat lesions like carcinoma in situ, can be missed without direct visualization.
Special Consideration for Single Episode
While the guidelines acknowledge that a single episode of microhematuria in truly low-risk patients might not require full evaluation, age ≥60 years overrides this consideration 1. The risk of delayed bladder cancer diagnosis in this age group outweighs the risks and costs of cystoscopy, which can be performed safely in the office setting with flexible cystoscopy under local anesthesia 3.